104 related articles for article (PubMed ID: 38250151)
1. Nε-carboxymethyl-lysine and inflammatory cytokines, markers and mediators of coronary artery disease progression in diabetes.
Eiras S
World J Diabetes; 2024 Apr; 15(4):575-578. PubMed ID: 38680703
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer.
Khoo SH; Wu PR; Yeh KT; Hsu SL; Wu CH
J Food Drug Anal; 2023 Dec; 31(4):664-682. PubMed ID: 38526823
[TBL] [Abstract][Full Text] [Related]
3. Increased accumulation of the advanced glycation endproduct Ne(carboxymethyl) lysine in the intramyocardial vasculature in patients with epicarditis.
Baylan U; Baidoshvili A; Simsek S; Schalkwijk CG; Niessen H; Krijnen P
Int J Exp Pathol; 2024 Apr; 105(2):48-51. PubMed ID: 38062984
[TBL] [Abstract][Full Text] [Related]
4. Determination of AGE-CML Level in Commercially Available Sports Bar in Italy.
Cannataro R; Elechi JOG; La Torre C; Fazio A; Abrego-Grandique DM; Caroleo MC; Cione E
Recent Adv Food Nutr Agric; 2024 Apr; ():. PubMed ID: 38616745
[TBL] [Abstract][Full Text] [Related]
5. Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.
Liao D; Zhong L; Yin J; Zeng C; Wang X; Huang X; Chen J; Zhang H; Zhang R; Guan XY; Shuai X; Sui J; Gao S; Deng W; Zeng YX; Shen JN; Chen J; Kang T
Nat Cell Biol; 2024 Mar; 26(3):490. PubMed ID: 38316985
[No Abstract] [Full Text] [Related]
6. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
[TBL] [Abstract][Full Text] [Related]
7. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
[TBL] [Abstract][Full Text] [Related]
8. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-derived advanced glycation end products-Nε-(carboxymethyl) lysine promotes RIP3-mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia/reperfusion injury.
Yang J; Zhang F; Shi H; Gao Y; Dong Z; Ma L; Sun X; Li X; Chang S; Wang Z; Qu Y; Li H; Hu K; Sun A; Ge J
FASEB J; 2019 Dec; 33(12):14410-14422. PubMed ID: 31665609
[TBL] [Abstract][Full Text] [Related]
10. Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.
Gaens KH; Goossens GH; Niessen PM; van Greevenbroek MM; van der Kallen CJ; Niessen HW; Rensen SS; Buurman WA; Greve JW; Blaak EE; van Zandvoort MA; Bierhaus A; Stehouwer CD; Schalkwijk CG
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1199-208. PubMed ID: 24723555
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
12. The advanced glycation end-product N
Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
[TBL] [Abstract][Full Text] [Related]
13. RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer.
Magna M; Hwang GH; McIntosh A; Drews-Elger K; Takabatake M; Ikeda A; Mera BJ; Kwak T; Miller P; Lippman ME; Hudson BI
NPJ Breast Cancer; 2023 Jul; 9(1):59. PubMed ID: 37443146
[TBL] [Abstract][Full Text] [Related]
14. Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Arch Toxicol; 2023 Aug; 97(8):2231-2244. PubMed ID: 37314482
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
